Medicare will require data on patient use for approved Alzheimer's drugs
The Medicare health plan will cover new Alzheimer's drugs after full U.S. approval for patients who participate in
2023-06-01 23:27
Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 billion a year, study finds
(This May 11 story has been corrected to change some wording in the quote by Dr. Mafi in paragraph 15)
2023-05-13 06:52